Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?
Keywords:Anemia/drug therapy, Renal Insufficiency, Chronic
Farinha A, Robalo Nunes A, Mairos J, Fonseca C. Anemia da doença renal crónica: o estado da arte. Acta Med Port. 2022;35:758–64. DOI: https://doi.org/10.20344/amp.17284
European Medicines Agency. Roxadustat. 2022. [consultado 2022 nov 18]. Disponível em:https://www.ema.europa.eu/en/documents/product-information/evrenzo-epar-product-information_en.pdf.
Locatelli F, Minutolo R, de Nicola L, del Vecchio L. Evolving strategies in the treatment of anaemia in chronic kidney disease: the HIF-prolyl hydroxylase inhibitors. Drugs. 2022;82:1565–89. DOI: https://doi.org/10.1007/s40265-022-01783-3
McCallum W, Weiner DE. HIF-PHIs for anemia management in CKD. Clin J Am Soc Nephrol. 2022;17:1255–8. DOI: https://doi.org/10.2215/CJN.02440222
Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021;99:1280–95. DOI: https://doi.org/10.1016/j.kint.2021.03.020
How to Cite
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.